ArticleProbiotics and antimicrobial proteins2026
Enterococcus faecalis NBRC 100481 Protects the Intestinal Barrier via α-catenin/HMP-1 in Caenorhabditis elegans.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Intestinal barrier disruption is a hallmark of gastrointestinal disorders and is also linked to metabolic diseases, posing serious health risks. Probiotic-based interventions have thus attracted growing attention. This study isolated Enterococcus faecalis NBRC 100481 from recovered colitis mice after dietary intervention with pentagalloyl glucose (PGG), and evaluated its protective effects and PGG's regulatory role. Fermentation revealed that PGG enhanced metabolic activity of E. faecalis NBRC 100481 and promoted production of bioactive metabolites such as N-acetylglutamic acid and 4-hydroxybenzaldehyde, which reduced intestinal permeability in Caenorhabditis elegans model. The strain also modulated host responses by preserving epithelial structure and suppressing aberrant expression of VHA-6. Its protective effects were abolished in zoo-1 and hmp-1 mutant worms, suggesting a dependence on host adhesion protein-related pathways. Notably, it attenuated the injury-induced upregulation of α-catenin/HMP-1 in worms with intestinal injury. Collectively, E. faecalis NBRC 100481, modulated by PGG, enhances intestinal barrier function through coordinated microbial metabolite production and host regulatory pathways, with the α-catenin/HMP-1 axis involved as a downstream component. This study offers new insights into polyphenol-probiotic-host interactions and provides strain-level evidence for probiotic-based barrier repair strategies.
Indexed as
Identifiers
42412325What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.